CRISPR-Cas9,IRF1-SOCS1,CXCL9

Imran G House1, Emily B Derrick1, Kevin Sek1

  • 1Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.

Cell reports
|August 22, 2023
PubMed
概括

研究人员发现,准IRF1或SOCS1可以促进巨细胞中CXCL9的表达,从而增强抗瘤免疫力. 这一发现为改善免疫检查点阻塞疗法的有效性提供了新的策略.